Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?

J Rehabil Med. 2008 Nov;40(10):882-3. doi: 10.2340/16501977-0257.
No abstract available

Publication types

  • Letter

MeSH terms

  • Botulinum Toxins / adverse effects
  • Botulinum Toxins / therapeutic use*
  • Botulinum Toxins, Type A / adverse effects
  • Botulinum Toxins, Type A / therapeutic use*
  • Humans
  • Neuromuscular Agents / adverse effects
  • Neuromuscular Agents / therapeutic use*
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy*
  • Sialorrhea / drug therapy*
  • Sialorrhea / etiology
  • Treatment Outcome

Substances

  • Neuromuscular Agents
  • rimabotulinumtoxinB
  • Botulinum Toxins
  • Botulinum Toxins, Type A